26 June 2017
: Case report
Extraovarian Primary Peritoneal Carcinomatosis: A Case Report
Challenging differential diagnosis, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Gregory Nicolas1ACDEF*, Tony Kfoury2AEFG, Hassan Fawaz2BDFG, Mahdi Issa2DFGDOI: 10.12659/AJCR.902801
Am J Case Rep 2017; 18:714-718
Abstract
BACKGROUND: Extraovarian primary peritoneal carcinoma (EOPPC) is a rare malignant epithelial tumor with an age-adjusted incidence rate of 6.78 per million, which arises from the peritoneal lining with minimal or no ovarian involvement. EOPPC is a diagnosis of exclusion with the absence of other identifiable primary sites and after surgical assessment and consideration of the histological report to evaluate the extent of ovarian invasion.
CASE REPORT: A 66-year-old woman complained of mild postprandial epigastric pain. Physical exam revealed positive bowel sounds over all 4 quadrants, with a soft, non-tender abdomen. Distension and dullness to percussion were noted. A CT scan revealed peritoneal fluid, and evaluation of the peritoneal fluid showed an elevated white blood cell count, while fulfilling criteria for exudate. There was no bacterial growth from the peritoneal fluid. Serum tumor markers CEA were significantly elevated, suggestive of an underlying malignancy. An exploratory laparoscopy confirmed diffuse carcinomatosis in the omentum, the coloparietal region bilaterally, as well as surrounding small bowel loops, the transverse and sigmoid colon, and the rectum. A bilateral oophorectomy was performed and 2 biopsies from the thickened peritoneum were taken. The histomorphological features from the pathology examination concluded the patient had peritoneal serous carcinoma with uninvolved ovaries.
CONCLUSIONS: EOPPC may be misdiagnosed as epithelial ovarian cancer, and should be considered in patients with peritoneal carcinomatosis, normal-sized ovaries, and no identifiable primary lesion. Since the common therapeutic strategies achieve comparable survival rates, failed recognition may be without consequences. However, to further improve survival, optimal cytoreductive surgery is essential and should be made a priority in disease management.
Keywords: Laparoscopes, Medical Oncology, Oncology Service, Hospital
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946269
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948017
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946852
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947099
Most Viewed Current Articles
21 Jun 2024 : Case report
93,520
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,161
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
27,932
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,978
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030